JENBURKT PHARMACEUTICALS
|
The Current P/E Ratio of JENBURKT PHARMACEUTICALS is 12.71.
| Share Price | ₹948.4 | Sep 25,2026 |
| Market Cap | ₹417.3 Cr | |
| Earnings-TTM | ₹32.8 Cr | TTM-Standalone Results |
| Price/Earnings | 12.71x | Calculated as Market Cap/Earnings |
|---|---|---|
| Explore Stock Analytics | ||
Definition & Calculation of PE (Price/Earnings) ratio of JENBURKT PHARMACEUTICALS
P/E =
Market Capitalization
/ Net Income
or, using per-share numbers:
P/E = Stock Price /
Earnings Per Share (EPS)
Current Market Cap [ ₹417.3 Cr] as on Sep 25,2026
(/) Earnings [ ₹32.8 Cr] based on TTM-Standalone Results
(=) P/E Ratio [ 12.71x ]
Thus, for JENBURKT PHARMACEUTICALS , the investors are currently willing to pay 12.71 times earnings to own 1 share of the company.
PE Multiples are the most widely used valuation multiple in practice.
Since P/E ratio uses Net Income in the calculation, P/E multiples are not always reliable for valuing companies with negative earnings.
In such cases, you may consider using Price to Book ratio or Price to Sales ratio of JENBURKT PHARMACEUTICALS !
P/E ratios, also, would not adjust for differences in the capital structure between companies.
The chart below summarizes the trend in P/E Ratio of JENBURKT PHARMACEUTICALS over the last five years.
Historical PE (Price/Earnings) ratio chart of JENBURKT PHARMACEUTICALS
PE Ratio Performance Analysis for JENBURKT PHARMACEUTICALS
- JENBURKT PHARMACEUTICALS 's p/e ratio for fiscal years ending Mar2026 to Mar2022 averaged 12.28x.
- JENBURKT PHARMACEUTICALS 's operated at median p/e ratio of 11.94x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, JENBURKT PHARMACEUTICALS 's p/e ratio peaked in Mar2025 at 13.93x.
- JENBURKT PHARMACEUTICALS 's p/e ratio hit its five-year low in Mar2022 of 11.66x.
How does JENBURKT PHARMACEUTICALS 's P/E Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
| Peer Comparison (Pharmaceuticals & Drugs Industry) | Earnings-TTM (Cr) | PE Ratio | Market Cap |
|---|---|---|---|
| JENBURKT PHARMACEUTICALS | 32.83 | 12.71 | 417.3 |
| SUN PHARMACEUTICAL INDUSTRIES LTD | 12,172.70 | 36.53 | 444,717.0 |
| DIVIS LABORATORIES LTD | 2,925.00 | 87.22 | 255,115.0 |
| TORRENT PHARMACEUTICALS LTD | 2,156.00 | 87.95 | 189,613.0 |
| CIPLA LTD | 3,364.84 | 33.55 | 112,876.0 |
| DR REDDYS LABORATORIES LTD | 3,169.30 | 31.68 | 100,395.0 |
| MANKIND PHARMA LTD | 2,055.11 | 49.75 | 102,247.0 |
| LUPIN LTD | 5,551.01 | 17.22 | 95,573.6 |
| ZYDUS LIFESCIENCES LTD | 4,492.20 | 26.69 | 119,900.0 |
| AUROBINDO PHARMA LTD | 3,712.74 | 26.52 | 98,464.4 |
| LAURUS LABS LTD | 1,090.76 | 99.12 | 108,116.0 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PE Analysis vs JENBURKT PHARMACEUTICALS 's P/E Ratio
| Top 10 Industry Peers | PE Ratio |
|---|---|
| Min industry PE | 12.71x |
| Max industry PE | 99.12x |
| Median industry PE | 33.55x |
| Average industry PE | 46.27x |
You may also like the below Video Courses